Skip to main content
REGN
NASDAQ Life Sciences

Regeneron Invests Up to $200M in TriNetX for Access to 300M Patient Database

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$761.54
Mkt Cap
$79.159B
52W Low
$476.487
52W High
$821.11
52W Position info
60% above low
Off High info
7.3% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

REGN sits 60% above its 52-week low of $476.487.

Summary

Regeneron Pharmaceuticals has entered into a strategic partnership with TriNetX, investing up to $200 million to gain access to TriNetX's network of 300 million anonymized patient records. This collaboration will allow Regeneron to expand its electronic health record-linked database by connecting its large-scale genomic and proteomic data cohorts. This move is highly beneficial as it directly enhances Regeneron's drug discovery and development pipeline, a critical driver for its therapeutics. The access to such a vast and diverse dataset is a significant strategic advantage, supporting future product innovation and complementing recent positive news regarding Dupixent and EYLEA HD approvals.

At the time of this announcement, REGN was trading at $761.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $79.2B. The 52-week trading range was $476.49 to $821.11. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

REGN - Latest Insights

REGN
Nov 08, 2026, 4:00 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $900.00
Real-time Price: $950.03 info
Change: +$50.03 (+6%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 12:34 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $910.52
Real-time Price: $950.03 info
Change: +$39.51 (+4%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $856.00
Real-time Price: $950.03 info
Change: +$94.03 (+11%) info
Market Cap: $98.825B info
REGN
Oct 30, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $835.00
Real-time Price: $950.03 info
Change: +$115.03 (+14%) info
Market Cap: $98.825B info
REGN
Oct 12, 2026, 12:06 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $764.45
Real-time Price: $950.03 info
Change: +$185.58 (+24%) info
Market Cap: $98.825B info